Pear Therapeutics

About:

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

Website: http://peartherapeutics.com

Twitter/X: Pear_Tx

Top Investors: Temasek Holdings, Novartis, Neuberger Berman, Perceptive Advisors, SoftBank Vision Fund

Description:

Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

Total Funding Amount:

$409M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)peartherapeutics.com

Founders:

Stephen Smith, Walter Greenleaf, William Greene

Number of Employees:

101-250

Last Funding Date:

2021-12-06

IPO Status:

Public

© 2025 bioDAO.ai